These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33168738)

  • 1. Excess of the NF-ĸB p50 subunit generated by the ubiquitin ligase KPC1 suppresses tumors via PD-L1- and chemokines-mediated mechanisms.
    Kravtsova-Ivantsiv Y; Goldhirsh G; Ivantsiv A; Ben Itzhak O; Kwon YT; Pikarsky E; Ciechanover A
    Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29823-29831. PubMed ID: 33168738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A short binding site in the KPC1 ubiquitin ligase mediates processing of NF-κB1 p105 to p50: A potential for a tumor-suppressive PROTAC.
    Goldhirsh G; Kravtsova-Ivantsiv Y; Satish G; Ziv T; Brik A; Ciechanover A
    Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34873064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NF-ĸB p50 subunit generated by KPC1-mediated ubiquitination and limited proteasomal processing, suppresses tumor growth.
    Kravtsova-Ivantsiv Y; Goldhirsh G; Tomuleasa C; Pikarsky E; Ciechanover A
    Cancer Cell Int; 2023 Apr; 23(1):67. PubMed ID: 37055826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The p105 NF-ĸB precursor is a pseudo substrate of the ubiquitin ligase FBXO7, and its binding to the ligase stabilizes it and results in stimulated cell proliferation.
    Udasin RG; Gottfried Y; Fabre B; Bercovich B; Ziv T; Ciechanover A
    Biochem Biophys Res Commun; 2021 Jun; 558():224-230. PubMed ID: 32933748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KPC1-mediated ubiquitination and proteasomal processing of NF-κB1 p105 to p50 restricts tumor growth.
    Kravtsova-Ivantsiv Y; Shomer I; Cohen-Kaplan V; Snijder B; Superti-Furga G; Gonen H; Sommer T; Ziv T; Admon A; Naroditsky I; Jbara M; Brik A; Pikarsky E; Kwon YT; Doweck I; Ciechanover A
    Cell; 2015 Apr; 161(2):333-47. PubMed ID: 25860612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus 1 E3 ubiquitin ligase ICP0 protein inhibits tumor necrosis factor alpha-induced NF-κB activation by interacting with p65/RelA and p50/NF-κB1.
    Zhang J; Wang K; Wang S; Zheng C
    J Virol; 2013 Dec; 87(23):12935-48. PubMed ID: 24067962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitin ligase TRUSS augments the expression of interleukin-10 via proteasomal processing of NF-κB1/p105 to NF-κB/p50.
    Jamal A; Husein A; Bihari C; Kumar V
    Cell Signal; 2020 Nov; 75():109766. PubMed ID: 32889079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemerin Reactivates PTEN and Suppresses PD-L1 in Tumor Cells via Modulation of a Novel CMKLR1-mediated Signaling Cascade.
    Rennier K; Shin WJ; Krug E; Virdi G; Pachynski RK
    Clin Cancer Res; 2020 Sep; 26(18):5019-5035. PubMed ID: 32605911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of different nuclear factor kappaB dimers on the survival of immortalized neural progenitor cells].
    Gui LL; Zhang CH; Liu ZH; Chen ZJ; Zhu C
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(13):871-5. PubMed ID: 18756949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-kappa B p50/p65 affects the frequency of Ly49 gene expression by NK cells.
    Pascal V; Nathan NR; Claudio E; Siebenlist U; Anderson SK
    J Immunol; 2007 Aug; 179(3):1751-9. PubMed ID: 17641041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappaB signalling proteins p50/p105, p52/p100, RelA, and IKKepsilon are over-expressed in oesophageal squamous cell carcinomas.
    Kang MR; Kim MS; Kim SS; Ahn CH; Yoo NJ; Lee SH
    Pathology; 2009; 41(7):622-5. PubMed ID: 20001340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Tumor Suppressor Functions of Ubiquitin Ligase KPC1: From Cell-Cycle Control to NF-κB Regulator.
    Gulei D; Drula R; Ghiaur G; Buzoianu AD; Kravtsova-Ivantsiv Y; Tomuleasa C; Ciechanover A
    Cancer Res; 2023 Jun; 83(11):1762-1767. PubMed ID: 36880841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ubiquitin-proteasome system and activation of NF-κB: involvement of the ubiquitin ligase KPC1 in p105 processing and tumor suppression.
    Kravtsova-Ivantsiv Y; Ciechanover A
    Mol Cell Oncol; 2015; 2(4):e1054552. PubMed ID: 27308511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.
    de Oliveira KA; Kaergel E; Heinig M; Fontaine JF; Patone G; Muro EM; Mathas S; Hummel M; Andrade-Navarro MA; Hübner N; Scheidereit C
    Genome Med; 2016 Mar; 8(1):28. PubMed ID: 26988706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NF-κB p65 and p50 homodimer cooperate with IRF8 to activate iNOS transcription.
    Simon PS; Sharman SK; Lu C; Yang D; Paschall AV; Tulachan SS; Liu K
    BMC Cancer; 2015 Oct; 15():770. PubMed ID: 26497740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations.
    Fabian KP; Padget MR; Donahue RN; Solocinski K; Robbins Y; Allen CT; Lee JH; Rabizadeh S; Soon-Shiong P; Schlom J; Hodge JW
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32439799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A20 inhibits both the degradation and limited processing of the NF-κB p105 precursor: A novel additional layer to its regulator role.
    Lapid D; Lahav-Baratz S; Cohen S
    Biochem Biophys Res Commun; 2017 Nov; 493(1):52-57. PubMed ID: 28923245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orientia tsutsugamushi modulates cellular levels of NF-κB inhibitor p105.
    Wangsanut T; Brann KR; Adcox HE; Carlyon JA
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009339. PubMed ID: 33857149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolvin D1 stimulates efferocytosis through p50/p50-mediated suppression of tumor necrosis factor-α expression.
    Lee HN; Kundu JK; Cha YN; Surh YJ
    J Cell Sci; 2013 Sep; 126(Pt 17):4037-47. PubMed ID: 23788426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 3: PD-L1, Intracellular Signaling Pathways and Tumor Microenvironment.
    Palicelli A; Croci S; Bisagni A; Zanetti E; De Biase D; Melli B; Sanguedolce F; Ragazzi M; Zanelli M; Chaux A; Cañete-Portillo S; Bonasoni MP; Soriano A; Ascani S; Zizzo M; Castro Ruiz C; De Leo A; Giordano G; Landriscina M; Carrieri G; Cormio L; Berney DM; Gandhi J; Copelli V; Bernardelli G; Santandrea G; Bonacini M
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.